The role of the nervous system in hematopoietic stem cell mobilization

Laboratory Hematology

Volumn 19, Issue 3, 2013, Pages 8-16

  Saba, Fakhredin ^a   Soleimani, Masoud ^a   Atashi, Amir ^a   Mortaz, Esmaeil ^b,c   Shahjahani, Mohammad ^a   Roshandel, Elham ^d   Jaseb, Kaveh ^e   Saki, Najmaldin ^e,f  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b UTRECHT UNIVERSITY   (Netherlands)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHAHID BEHESHTI UNIVERSITY   (Iran)

^e AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f STEM CELL TECHNOLOGY RESEARCH CENTER   (Iran)

Author keywords

Hematopoietic stem cells; Mobilization; Nervous system

Indexed keywords

ADRENERGIC RECEPTOR; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CATECHOLAMINE; CHEMOKINE RECEPTOR CXCR4; CYCLIC AMP; CYCLOPHOSPHAMIDE; DOPAMINE; GELATINASE B; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; INTEGRIN; INTERLEUKIN 8; LEUKOCYTE ELASTASE; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NORADRENALIN; OPIATE RECEPTOR; OREXIN 1 RECEPTOR; OREXIN 2 RECEPTOR; PLERIXAFOR; PROTEIN KINASE C; PROTEINASE; SERINE PROTEINASE; SOMATOSTATIN; SOMATOSTATIN RECEPTOR; STROMAL CELL DERIVED FACTOR 1; TACHYKININ RECEPTOR; TRANSCRIPTION FACTOR SP1; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADRENERGIC SYSTEM; ARTICLE; BONE REMODELING; CALCIUM CELL LEVEL; CATECHOLAMINE NERVE CELL; CATECHOLAMINE RELEASE; CELL ADHESION; CELL GROWTH; CELL PROLIFERATION; ENVIRONMENTAL FACTOR; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; NERVOUS SYSTEM FUNCTION; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; SIGNAL TRANSDUCTION; STEADY STATE; STEM CELL MOBILIZATION; STRESS; STROMA CELL;

HEMATOPOIETIC STEM CELLS; MOBILIZATION; NERVOUS SYSTEM;

ANIMALS; BONE MARROW CELLS; CHEMOKINE CXCL12; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; NERVOUS SYSTEM; PROTEOLYSIS; RECEPTORS, CXCR4; SIGNAL TRANSDUCTION;

EID: 84892760173     PISSN: 10802924     EISSN: None     Source Type: Journal    
DOI: 10.1532/LH96.12013     Document Type: Article

References (94)

1. Can A. Haematopoietic stem cells niches: interrelations between structure and function. Transfus Apher Sci. 2008;38:261-268.
2. Saki N, Abroun S, Hagh M.F., Asgharei F. Neoplastic bone marrow niche: hematopoietic and mesenchymal stem cells. Cell Journal (Yakhteh). 2011;13:131-6.
3. Martinez-Agosto J.A., Mikkola HKA, Hartenstein V, Banerjee U. The hematopoietic stem cell and its niche: a comparative view. Genes Dev. 2007;21:3044-60.
4. Lapidot T, Kollet O. The brain-bone-blood triad: traffic lights for stem-cell homing and mobilization. Hematology Am Soc Hematol Educ Program. 2010;2010:1-6.
5. Wright DE, Wagers AJ, Gulati, AP, Johnson F.L., Weissman IL Physi-ological migration of hematopoietic stem and progenitor cells. Science. 2001;294:1933-6.
6. Kubota Y, Kimura S. Regulators of the proliferation of hematopoietic stem and progenitor cells during hematopoietic regeneration. In: Alimoghaddam K, ed., Stem Cell Biology in Normal Life and Diseases. 2013. Available at: http://www.intechopen.com/books/stem-cell-biology-in-normal-life-and-diseases/ regulators-of-the-proliferation-of-hematopoietic-stem-and-progenitor-cells- during-hematopoietic-rege
7. To LB, Haylock DN, Simmons P.J., Juttner CA The biology and clinical uses of blood stem cells. Blood. 1997;89:2233-58.
8. Zaldivar F, Eliakim A, Radom-Aizik S, Leu S.Y., Cooper DM The effect of brief exercise on circulating CD34+ stem cells in early and late pubertal boys. Pediatr Res. 2007;61:491-5.
9. Jeong M, Piao ZH, Kim MS, et al. Thioredoxin-interacting protein regulates hematopoietic stem cell quiescence and mobilization under stress conditions. J Immunol. 2009;183:2495-505.
10. Blanchet MR, McNagny KM Stem cells, inflammation and allergy. Allergy Asthma Clin Immunol. 2009;5:13.
11. Takizawa H, Boettcher S, Manz MG Demand-adapted regulation of early hematopoiesis in infection and infammation. Blood. 2010;119:2991-3002.
12. Winkler IG, Pettit AR, Raggatt LJ, et al. Hematopoietic stem cell mobilizing agents G-CSF, cyclophosphamide or AMD3100 have distinct mechanisms of action on bone marrow HSC niches and bone formation. Leukemia. 2012;26:1594-601.
13. Pesek G, Cottler-Fox M. Hematopoietic stem cell mobilization: a clinical protocol. Methods Mol Biol. 2012;904:69-77.
14. Link DC. Mechanisms of granulocyte colony-stimulating factor-induced hematopoietic progenitor-cell mobilization. Semin Hematol. 2000;37:25-32.
15. To LB, Levesque JP, Herbert KE How I treat patients who mobilize hematopoietic stem cells poorly. Blood. 2011;118:4530-40.
16. Hattori K, Heissig B, Rafii S. The regulation of hematopoietic stem cell progenitor mobilization by chemokine SDF-1. Leuk Lymphoma. 2003;44:575-82.
17. Pruijt J.F., Verzaal P, van Os R, et al Neutrophils are indispensable for hematopoietic stem cell mobilization induced by interleukin-8 in mice. Proc Natl Acad Sci U S A. 2002;99:6228-33.
18. King AG, Dillon S, Horowitz D., et al Mechanism of action of truncated GRO((SB-251353)-induced stem cell mobilization: role of the CXCR2 receptor and matrix metalloproteinase-9 (MMP-9) enzyme activity [abstract]. Exp Hematol. 1999;27:127a.
19. Hutson S.P., Han PKJ, Hamilton JG, et al The use of haematopoietic stem cell transplantation in Fanconi anaemia pateitns: a survey of decision making among families in the US and Canada. Health Expectations. 2013. doi:10.1111/hex.12066.
20. Cavazzana-Calvo M., André-Schmutz I, Fischer A. Haematopoietic stem cell transplantation for SCID patients: where do we stand? Br J Haematol. 2013;160:146-52.
21. Hamilton BK, Copelan EA Concise review: the role of hemato-poietic stem cell transplantation in the treatment of acute myeloid leukemia. Stem Cells. 2012;30:1581-6.
22. Kamimura T, Miyamoto T, Kawano N., et al Successful treatment by donor lymphocyte infustion of adult T-cell leukemia/ lymphoma relapse following allogeneic hematopoietic stem cell transplantation. Int J Hematol. 2012;95:725-30.
23. Gallardo D, de la Cámera R, Nieto JB, et al. Is mobilized peripheral blood comparable with bone marrow as a source of hema-topoietic stem cells for allogeneic transplantation from HLA-identical sibling donors? A case-control study. Haematologica. 2009;94:1282-8.
24. Suárez-Alvarez B., López-Vázquez A, López-Larrea C. Mobilization and homing of hematopoietic stem cells. Adv Exp Med Biol. 2012;741:152-70.
25. Sancho JM, Morgandes M, Grifols J.R., et al Predictive factors for poor peripheral blood stem cell mobilization and peak CD34(+) cell count to guide pre-emptive or immediate rescue mobilization. Cytotherapy. 2012;14:823-9.
26. Lucas D, Bruns I, Battista M., et al Norepinephrine reuptake inhibition promotes mobilization in mice: potential impact to rescue low stem cell yields. Blood. 2012;119:3962-5.
27. Gur-Cohen S., Lapid K, Lapidot T. Quantifying hematopoi-etic stem and progenitor cell mobilization. Methods Mol Biol. 2012;904:15-35.
28. Mignini F, Streccioni V, Amenta F. Autonomic innervation of immune organs and neuroimmune modulation. Auton Autocoid Pharmacol. 2003;23:1-25.
29. Tabarowski Z, Gibson-Berry K, Felten SY Noradrenergic and peptidergic innervation of the mouse femur bone marrow. Acta Histochem. 1996;98:453-7.
30. Nance DM, Sanders VM Autonomic innervation and regulation of the immune system (1987-2007). Brain Behav Immun. 2007;21:736-45.
31. Nadri S, Soleimani M, Mobarra Z., Amini S. Expression of dopa-mine-associated genes on conjunctiva stromal-derived human mesenchymal stem cells. Biochem Biophys Res Commun. 2008;377;423-8.
32. Afan AM, Broome CS, Nicholls S.E., Whetton AD, Miyan JA Bone marrow innervation regulates cellular retention in the murine haemopoietic system. Br J Haematol. 1997;98:569-77.
33. Kalinkovich A, Spiegel A, Shivtiel S., et al Blood-forming stem cells are nervous: direct and indirect regulation of immature human CD34+ cells by the nervous system. Brain Behav Immun. 2009;23:1059-65.
34. Muthu K, Iyer S, He L.K., et al Murine hematopoietic stem cells and progenitors express adrenergic receptors. J Neuroimmunol. 2007;186:27-36.
35. Spiegel A Shivtiel S, Kalinkovich A, et al. Catecholaminergic neurotransmitters regulate migration and repopulation of immature human CD34+ cells through Wnt signaling. Nat Immunol. 2007;8:1123-31.
36. Seidel J, Niggemann B, Punzel M., Fischer J, Zänker KS, Dittmar T. The neurotransmitter GABA is a potent inhibitor of the stromal cell-derived factor-1alpha induced migration of adult CD133+ hematopoietic stem and progenitor cells. Stem Cells Dev. 2007;16:827-36.
37. Hoggatt J, Pelus LM Many mechanisms mediating mobilization: an alliterative review. Curr Opin Hematol. 2011;18:231-8.
38. Steidl U, Bork S, Schaub S., et al Primary human CD34+ hemato-poietic stem and progenitor cells express functionally active receptors of neuromediators. Blood. 2004. 1004;104:81-8.
39. Murthy RG, Reddy BY, Ruggiero J.E., Rameshwar P. Tachykinins and hematopoietic stem cell functions: implications in clinical disorders and tissue regeneration. Front Biosci. 2007;12:4779-87.
40. Harzenetter MD, Keller U, Beer S., Riedl C, Peschel C, Holzmann B. Regulation and function of the CGRP receptor complex in human granulopoiesis. Exp Hematol. 2002;30:306-12.
41. Sengupta R, Burbassi S, Shimizu S., et al Morphine increases brain levels of ferritin heavy chain leading to inhibition of CXCR4-mediated survival signaling in neurons. J Neurosci. 2009;29:2534-44.
42. Kawakami M, Kimura T, Kishimoto Y., et al Preferential expression of the vasoactive intestinal peptide (VIP) receptor VPAC1 in human cord blood-derived CD34+CD38-cells: possible role of VIP as a growth-promoting factor for hematopoietic stem/progenitor cells. Leukemia. 2004;18;912-21.
43. Ferone D, Boschetti M, Resmini E., et al Neuroendocrine-immune interactions: the role of cortistatin/somatostatin system. Ann N Y Acad Sci. 2006;1069:129-44.
44. Méndez-Ferrer S., Lucas D, Battista M., Frenette PS Haematopoietic stem cell release is regulated by circadian oscillations. Nature. 2008;452:442-7.
45. Katayama Y, Battista M, Kao W.M., et al Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell. 2006;124:407-21.
46. Lapidot T, Petit I. Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol. 2002;30:973-81.
47. Abroun S. Chemokines in homeostasis and cancers. Yakhteh Medical Journal. 2008;10:155-66.
48. Gazitt Y. Homing and mobilization of hematopoietic stem cells and hematopoietic cancer cells are mirror image processes, utilizing similar signaling pathways and occurring concurrently: circulating cancer cells constitute an ideal target for concurrent treatment with chemotherapy and antilineage-specific antibodies. Leukemia. 2004;18:1-10.
49. Nagasawa T, Hirota S, Tachibana K., et al Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature. 1996;382:635-8.
50. Petit I, Szyper-Kravitz M, Nagler A., et al G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol. 2002;3:687-94.
51. Moore MA, Hattori K, Heissig B., et al Mobilization of endothe-lial and hematopoietic stem and progenitor cells by adenovector-mediated elevation of serum levels of SDF-1, VEGF, and agiopoi-etin-1. Ann N Y Acad Sci. 2001;938:36-45.
52. Burger JA, Kipps TJ CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood. 2006;107:1761-7.
53. Lavi E, Strizki JM, Ulrich A.M., et al CXCR-4 (Fusin), a co-receptor for the type 1 human immunodeficiency virus (HIV-1), is expressed in the human brain in a variety of cell types, including microglia and neurons. Am J Pathol. 1997;151:1035-42.
54. Spiegel A, Kalinkovich A, Shivtiel S., Kollet O, Lapidot T. Stem cell regulation via dynamic interactions of the nervous and immune systems with the microenvironment. Cell Stem Cell. 2008;3:484-92.
55. De Clercq E. Recent advances on the use of the CXCR4 antagonist plerixafor (AMD3100, Mozobil™) and potential of other CXCR4 antagonists as stem cell mobilizers. Pharmacol Ther. 2010;128:509-18.
56. Abraham M, Biyder K, Begin M., et al Enhanced unique pattern of hematopoietic cell mobilization induced by the CXCR4 antagonist 4F-benzoyl-TN14003. Stem Cells. 2007;25:2158-66.
57. Dar A, Schajnovitz A, Lapid K., et al Rapid mobilization of hematopoietic progenitors by AMD3100 and catecholamines is mediated by CXCR4-dependent SDF-1 release from bone marrow stromal cells. Leukemia. 2011;25:1286-96.
58. Semerad CL, Christopher MJ, Liu F, et al G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow. Blood. 2005;106:3020-7.
59. Méndez-Ferrer S., Battista M, Frenette PS Cooperation of beta(2)-and beta(3)-adrenergic receptors in hematopoietic progenitor cell mobilization. Ann N Y Acad Sci. 2010;1192:139-44.
60. Golan K, Vagima Y, Ludin A., et al S1P promotes murine progenitor cell egress and mobilization via S1P1-mediated ROS signaling and SDF-1 release. Blood. 2012;119:2478-88.
61. Tano N, Kim H W, Ashraf M. microRNA-150 regulates mobilization and migration of bone marrow-derived mononuclear cells by targeting Cxcr4. PLoS One. 2011;6:e23114.
62. von Solingen C., de Boer HC, Bijkerk R, et al MicroRNA-126 modulates endothelial SDF-1 expression and mobilization of Sca-1(+)/Lin(-) progenitor cells in ischaemia. Cardiovasc Res. 2011;92:449-55.
63. Kollet O, Dar A, Shivtiel S., et al Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nat Med. 2006;12:657-64.
64. Sahin AO, Buitenhuis M. Molecular mechanisms underlying adhesion and migration of hematopoietic stem cells. Cell Adh Migr. 2012;6:39-48.
65. Ries C, Egea V, Karow M., Kolb H, Jochum M, Neth P. MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by infam-matory cytokines. Blood. 2007;109:4055-63.
66. van Os R., van Schie ML, Willemze R, Fibbe WE Proteolytic enzyme levels are increased during granulocyte colony-stimulating factor-induced hematopoietic stem cell mobilization in human donors but do not predict the number of mobilized stem cells. J Hematother Stem Cell Res. 2002;11:513-21.
67. Lapid K, Vagima Y, Kollet O., Lapidot T. Egress and mobilization of hematopoietic stem and progenitor cells. In: StemBook [Internet] Cambridge, MA: Harvard Stem Cell Institute. 2009.
68. Levesque J.P., Liu F, Simmons P.J., et al Characterization of hemato-poietic progenitor mobilization in protease-deficient mice. Blood. 2004;104:65-72.
69. Page-McCaw A., Ewald AJ, Werb Z. Matrix metalloproteinases and the regulation of tissue remodeling. Nat Rev Mol Cell Biol. 2007;8:221-33.
70. Heissig B, Hattori K, Dias S., et al Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell. 2002;109:625-37.
71. Shirvaikar N, Marquez-Curtis LA, Shaw A.R., Turner AR, Janowska-Wieczorek A.MT-1-MMP association with membrane lipid rafts facilitates G-CSF-induced hematopoietic stem/progenitor cell mobilization. Exp Hematol. 2010;38:823-25.
72. Barbier V, Winkler IG, Lévesque J P. Mobilization of hematopoietic stem cells by depleting bone marrow macrophages. Methods Mol Biol. 2012;904:117-38.
73. Christopherson KW 2nd, Hangoc G, Manel CR, Broxmeyer HE. Modulation of hematopoietic stem cell homing and engraftment by CD26. Science. 2004;305:1000-3.
74. Vagima Y, Avigdor A, Goichberg P., et al MT1-MMP and RECK are involved in human CD34+ progenitor cell retention, egress, and mobilization. J Clin Invest. 2009;119:492-503.
75. Schneider A, Krüger C, Steigleder T., et al The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Invest. 2005;115:2083-98.
76. Golan K, Vagima Y, Goichberg P., Gur-Cohen S, Lapidot T. MT1-MMP and RECK: opposite and essential roles in hematopoietic stem and progenitor cell retention and migration. J Mol Med (Berl). 2011;89:1167-74.
77. Lemaire V, Tobin FL, Greller L.D., Cho CR, Suva LJ Modeling the interactions between osteoblast and osteoclast activities in bone remodeling. J Theor Biol. 2004;229:293-309.
78. Shafiee A, Seyedjafari E, Soleimani M., Ahmadbeigi N, Dinarvand P, Ghaemi N. A comparison between osteogenic differention of human unrestricted somatic stem cells and mesenchymal stem cells from bone marrow and adipose tissue. Biotechnol Lett. 2011;33:1257-64.
79. Li J, Sarosi I, Yan X.Q., et al RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc Natl Acad Sci U S A. 2000;97:1566-71.
80. Gong JK. Endosteal marrow: a rich source of hematopoietic stem cells. Science. 1978;199:1443-5.
81. Khera S, Tiwari A, Srinivasan R., Gupta A, Luthra-Guptasarma M. Expression of granulocyte colony stimulating factor and its receptor by retinal pigment epithelial cells: a role in maintaining differentiation-competent state. Curr Eye Res. 2011;36:469-80.
82. Calvi LM, Adams GB, Weibrecht K.W., et al Osteoblastic cells regulate the haematopoietic stem cell niche. Nature. 2003;425:841-6.
83. Huang W, Yang S, Shao J., Li YP Singaling and transcriptional regulation in osteoblast commitment and differentiation. Front Biosci. 2007;12:3068-92.
84. Froberg MK, Garg UC, Stroncek D.F., Geis M., McCullough J, Brown DM Changes in serum osteocalcin and bone-specific alkaline phosphatase are associated with bone pain in donors receiving granulocyte-colony-stimulating factor for peripheral blood stem and progenitor cell collection. Transfusion. 1999;39:410-4.
85. Elefteriou F. Regulation of bone remodeling by the central and peripheral nervous system. Arch Biochem Biophys. 2008;473:231-6.
86. Togari A. Adrenergic regulation of bone metabolism: possible involvement of sympathetic innervation of osteoblastic and osteoclastic cells. Microsc Res Tech. 2002;58:77-84.
87. Li H, Fong C, Chen Y., Cai G, Yang M. beta2- and beta3-, but not beta1-adrenergic receptors are involved in osteogenesis of mouse mesenchymal stem cells via cAMP/PKA signaling. Arch Biochem Biophys. 2010;496:77-83.
88. Bonnet N, Pierroz DD, Ferrari SL Adrenergic control of bone remodeling and its implications for the treatment of osteoporosis. J Musculoskelet Neuronal Interact. 2008;8:94-104.
89. Takeda S, Elefteriou F, Levasseur R., et al Leptin regulates bone formation via the sympathetic nervous system. Cell. 2002;111:305-17.
90. Kondo H, Nifuji A, Takeda S., et al Unloading induces osteoblastic cell suppression and osteoclastic cell activation to lead to bone loss via sympathetic nervous system. J Biol Chem. 2005;280:30192-200.
91. Elefteriou F. Neuronal signaling and the regulation of bone remodeling. Cell Mol Life Sci. 2005;62:2339-49.
92. Uemura T, Ohta Y, Nakao Y., Manaka T, Nakamura H, Takaoka K. Epinephrine accelerates osteoblastic differentiation by enhancing bone morphogenetic protein signaling through a cAMP/protein kinase A signaling pathway. Bone. 2010;47:756-65.
93. Can A. Haematopoietic stem cells niches: interrelations between structure and function. Transfus Apher Sci. 2008;38:261-8.
94. Abroun S, Saki N, Fakher R., Asghari F. Biology and bioinformatics of myeloma cell. Lab Hematol. 2012;18:30-41.